Dodge & Cox Purchases 117,125 Shares of Cigna Group $CI

Key Points

• Dodge & Cox has increased its holdings in Cigna Group by 1.3%, acquiring an additional 117,125 shares in the first quarter, bringing their total ownership to 8,889,733 shares, valued at approximately $2.92 billion.
• Cigna Group reported an earnings per share (EPS) of $7.20 for the most recent quarter, exceeding analysts' expectations of $7.15, with quarterly revenue increasing by 11% year-over-year to $67.13 billion.
• The company has declared a quarterly dividend of $1.51 per share, which will be paid on September 18th, resulting in an annualized dividend yield of 2.0%.

Dodge & Cox lifted its position in Cigna Group (NYSE:CI - Free Report) by 1.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,889,733 shares of the health services provider's stock after acquiring an additional 117,125 shares during the quarter. Cigna Group accounts for 1.7% of Dodge & Cox's portfolio, making the stock its 19th largest position. Dodge & Cox owned about 3.33% of Cigna Group worth $2,924,722,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Putney Financial Group LLC purchased a new position in Cigna Group in the 4th quarter worth about $36,000. Evermay Wealth Management LLC increased its stake in Cigna Group by 58.6% in the 1st quarter. Evermay Wealth Management LLC now owns 111 shares of the health services provider's stock worth $37,000 after buying an additional 41 shares during the period. Richardson Financial Services Inc. purchased a new position in Cigna Group in the 1st quarter worth about $38,000. Wayfinding Financial LLC purchased a new position in Cigna Group in the 1st quarter worth about $40,000. Finally, Ameriflex Group Inc. purchased a new position in Cigna Group in the 4th quarter worth about $44,000. Institutional investors own 86.99% of the company's stock.

Cigna Group Trading Up 1.1%

NYSE:CI opened at $304.1390 on Friday. Cigna Group has a one year low of $256.89 and a one year high of $370.83. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The firm has a market cap of $81.18 billion, a P/E ratio of 16.60, a P/E/G ratio of 0.88 and a beta of 0.47. The firm has a 50-day simple moving average of $300.91 and a 200-day simple moving average of $311.39.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the previous year, the firm earned $6.72 EPS. The company's quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a $1.51 dividend. The ex-dividend date of this dividend is Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group's payout ratio is presently 32.97%.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares of the company's stock, valued at $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently commented on CI shares. Guggenheim reaffirmed a "buy" rating and issued a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $371.00 price target on shares of Cigna Group in a research note on Thursday, June 26th. TD Cowen raised shares of Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Morgan Stanley raised their target price on shares of Cigna Group from $379.00 to $390.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. Finally, Wells Fargo & Company reduced their price target on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $374.82.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.